Adynxx, Inc. (ADYX)
ADYX Stock Price Chart
Explore Adynxx, Inc. interactive price chart. Choose custom timeframes to analyze ADYX price movements and trends.
ADYX Company Profile
Discover essential business fundamentals and corporate details for Adynxx, Inc. (ADYX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Dec 1998
Employees
6.00
Website
https://www.adynxx.comCEO
Richard Orr
Description
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.
ADYX Financial Timeline
Browse a chronological timeline of Adynxx, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
ADYX Stock Performance
Access detailed ADYX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.